Towards Universal Access Scaling up priority HIV/AIDS interventions in the health sector, Progress Report, 2007. ,
Mortality of HIV-1-infected patients in the first year of antiretroviral therapy: comparison between low-income and high-income countries, Lancet, vol.367, pp.817-824, 2006. ,
Mortality and causes of death in adults receiving highly active antiretroviral therapy in Senegal: a 7-year cohort study, AIDS, vol.20, issue.8, pp.1181-1190, 2006. ,
DOI : 10.1097/01.aids.0000226959.87471.01
Medium-term survival, morbidity and immunovirological evolution in HIV-infected adults receiving antiretroviral therapy, Antivir Ther, vol.8, pp.385-393, 2003. ,
Cryptococcocal immune reconstitution disease: a major cause of early mortality in a South African antiretroviral programme, AIDS, vol.19, issue.17, pp.2050-2052, 2005. ,
DOI : 10.1097/01.aids.0000191232.16111.f9
Burden of tuberculosis in an antiretroviral treatment programme in sub-Saharan Africa: impact on treatment outcomes and implications for tuberculosis control, AIDS, vol.20, issue.12, pp.1605-1617, 2006. ,
DOI : 10.1097/01.aids.0000238406.93249.cd
CD4-guided structured antiretroviral treatment interruption strategy in HIV-infected adults in west Africa (Trivacan ANRS 1269 trial): a randomised trial, The Lancet, vol.367, issue.9527, pp.1981-1989, 2006. ,
DOI : 10.1016/S0140-6736(06)68887-9
Tolerance and Acceptability of an Efavirenz-Based Regimen in 740 Adults (Predominantly Women) in West Africa, JAIDS Journal of Acquired Immune Deficiency Syndromes, vol.42, issue.1, pp.29-35, 2006. ,
DOI : 10.1097/01.qai.0000219777.04927.50
Haematological changes in adults receiving a zidovudine-containing HAART regimen in combination with cotrimoxazole in Cote d'Ivoire, Antivir Ther, vol.10, pp.615-639, 2005. ,
Transfer and Evaluation of an Automated, Low-Cost Real-Time Reverse Transcription-PCR Test for Diagnosis and Monitoring of Human Immunodeficiency Virus Type 1 Infection in a West African Resource-Limited Setting, Journal of Clinical Microbiology, vol.43, issue.6, pp.2709-2717, 2005. ,
DOI : 10.1128/JCM.43.6.2709-2717.2005
Pattern of bacterial diseases in a cohort of HIV-1 infected adults receiving cotrimoxazole prophylaxis in Abidjan, C??te d'Ivoire, AIDS, vol.17, issue.4, pp.575-584, 2003. ,
DOI : 10.1097/00002030-200303070-00013
Risk Factors for Active Tuberculosis after Antiretroviral Treatment Initiation in Abidjan, American Journal of Respiratory and Critical Care Medicine, vol.172, issue.1, pp.123-127, 2005. ,
DOI : 10.1164/rccm.200410-1342OC
Scaling up of highly active antiretroviral therapy in a rural district of Malawi: an effectiveness assessment, The Lancet, vol.367, issue.9519, pp.1335-1377, 2006. ,
DOI : 10.1016/S0140-6736(06)68580-2
Rapid Scale-up of Antiretroviral Therapy at Primary Care Sites in Zambia, JAMA, vol.296, issue.7, pp.782-93, 2006. ,
DOI : 10.1001/jama.296.7.782
Long-Term Benefits of Highly Active Antiretroviral Therapy in Senegalese HIV-1-Infected Adults, JAIDS Journal of Acquired Immune Deficiency Syndromes, vol.38, issue.1, pp.14-21, 2005. ,
DOI : 10.1097/00126334-200501010-00003
Risk factors for high early mortality in patients on antiretroviral treatment in a rural district of Malawi, AIDS, vol.20, issue.18, pp.2355-60, 2006. ,
DOI : 10.1097/QAD.0b013e32801086b0
Generic fixed-dose combination antiretroviral treatment in resource-poor settings: multicentric observational cohort, AIDS, vol.20, issue.8, pp.1163-1172, 2006. ,
DOI : 10.1097/01.aids.0000226957.79847.d6
Adherence to antiretroviral therapy in a home-based AIDS care programme in rural Uganda, The Lancet, vol.368, issue.9547, pp.1587-94, 2006. ,
DOI : 10.1016/S0140-6736(06)69118-6
Initial Response to Highly Active Antiretroviral Therapy in HIV-1C-Infected Adults in a Public Sector Treatment Program in Botswana, JAIDS Journal of Acquired Immune Deficiency Syndromes, vol.40, issue.3, pp.336-379, 2005. ,
DOI : 10.1097/01.qai.0000159668.80207.5b
Outcomes after two years of providing antiretroviral treatment in Khayelitsha, South Africa, AIDS, vol.18, issue.6, pp.887-95, 2004. ,
DOI : 10.1097/00002030-200404090-00006
Short-term risk of AIDS or death in people infected with HIV-1 before antiretroviral therapy in South Africa: a longitudinal study, The Lancet, vol.368, issue.9543, pp.1254-1263, 2006. ,
DOI : 10.1016/S0140-6736(06)69117-4
Expert Consultation on Cotrimoxazole Prophylaxis in HIV Infection. WHO technical report series. Reference number: WHO/HIV, 2006. ,
Effect of co-trimoxazole prophylaxis on morbidity, mortality, CD4-cell count, and viral load in HIV infection in rural Uganda, The Lancet, vol.364, issue.9443, pp.1428-1462, 2004. ,
DOI : 10.1016/S0140-6736(04)17225-5
Early chemoprophylaxis with trimethoprim-sulphamethoxazole for HIV-1-infected adults in Abidjan, C??te d'Ivoire: a randomised trial, The Lancet, vol.353, issue.9163, pp.1463-1471, 1999. ,
DOI : 10.1016/S0140-6736(98)07399-1
Determinants of Mortality and Nondeath Losses from an Antiretroviral Treatment Service in South Africa: Implications for Program Evaluation, Clinical Infectious Diseases, vol.43, issue.6, pp.770-776, 2006. ,
DOI : 10.1086/507095
The Prognostic Importance of Changes in CD4^+Cell Count and HIV-1 RNA Level in Women after Initiating Highly Active Antiretroviral Therapy, Annals of Internal Medicine, vol.140, issue.4, pp.256-64, 2004. ,
DOI : 10.7326/0003-4819-140-4-200402170-00007
Risk Factors for Tuberculosis among HIV-infected Patients Receiving Antiretroviral Treatment, American Journal of Respiratory and Critical Care Medicine, vol.172, issue.10, pp.1348-1357, 1348. ,
DOI : 10.1164/ajrccm.172.10.1348
Relapse and recurrent tuberculosis in the context of a National Tuberculosis Control Programme, Transactions of the Royal Society of Tropical Medicine and Hygiene, vol.94, issue.3, pp.247-256, 2000. ,
DOI : 10.1016/S0035-9203(00)90306-7
DOT or not? Direct observation of antituberculosis treatment and patient outcomes, Int J Tuberc Lung Dis, vol.4, pp.409-422, 2000. ,
Lack of Directly Observed Treatment Affects Tuberculosis Relapse Rates, American Journal of Respiratory and Critical Care Medicine, vol.173, issue.3, pp.359-359, 2006. ,
DOI : 10.1164/ajrccm.173.3.359